bifemelane has been researched along with Adrenal Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishiki, R; Nagatsu, T; Naoi, M; Nomura, Y; Suzuki, H | 1 |
1 other study(ies) available for bifemelane and Adrenal Cancer
Article | Year |
---|---|
4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
Topics: Adrenal Gland Neoplasms; Animals; Antidepressive Agents; Benzhydryl Compounds; Binding, Competitive; Brain; Chemical Phenomena; Chemistry; Female; Humans; Kynuramine; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pheochromocytoma; Placenta; Pregnancy; Rats; Structure-Activity Relationship; Synaptosomes; Tumor Cells, Cultured | 1988 |